Fabio Rosati, a director at Xometry, Inc., has filed to sell 5,400 shares of the company's Class A common stock. This transaction is significant as it is part of a predetermined selling plan that aligns with SEC Rule 10b5-1(c). The sale occurred on November 9, 2026, and is valued at approximately $651,186.

Xometry, Inc., incorporated in Maryland, operates in the business services sector, specifically focusing on custom manufacturing solutions. The company is publicly traded under the ticker symbol XOM and is listed on the NASDAQ exchange. Recent filings indicate that Xometry has been active in the market, with Rosati's sales being part of a broader trend in the industry.

According to the SEC filing, Rosati acquired the shares being sold through an option exercise on September 2, 2020. The filing also states that Rosati's selling plan was adopted on August 10, 2026, indicating a structured approach to managing his investments in Xometry.

The filing highlights that Rosati's transactions may influence investor perceptions of Xometry, especially given the recent sales by the Fabio Rosati 2022 Family Trust, which sold 8,100 shares on August 10, 2026, and an additional 1,900 shares on August 11, 2026. These transactions collectively raised significant proceeds, reflecting Rosati's active management of his holdings in the company.

The filing does not specify what happens next regarding Rosati's selling plan or any future transactions. However, it underscores the ongoing activity within the business services industry as stakeholders react to market conditions.